DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / P•••••••••
I••• acquires P•••••••••, a Highly Potent API manufacturing site specializing in ophthalmology
Add-on acquisitionannouncedadd-onannounced Dec 18, 2025Fact
What happened
- Target
- P•••••••••
- Platform
- I•••add-on basis: I••• acquires P•••••••••, a Highly Potent API manufacturing site specializing in ophthalmology | I••• is held by K•••••••• C•••••• on its portfolio page; published on K•••••••• C••••••'s own news page
- Control
- Control
- Share acquired
- unknown
- Industry
- healthcare / pharma
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
4 named
Buy side
- “I••• acquires P•••••••••, a Highly Potent API manufacturing site specializing in ophthalmology | I••• is held by K•••••••• C•••••• on its portfolio page; published on K•••••••• C••••••'s own news page”
- “I••• acquires P•••••••••, a Highly Potent API manufacturing site specializing in ophthalmology | I••• is held by K•••••••• C•••••• on its portfolio page; published on K•••••••• C••••••'s own news page”
Side not stated
- “M••••• B••••, CEO at I•••, said: “P••••••••• and its team bring deep technical knowledge in ophthalmic HPAPIs and a strong operational base to I•••.”
- “I••• acquires P•••••••••, a Highly Potent API manufacturing site specializing in ophthalmology”
Evidence
“I••• acquires P•••••••••, a Highly Potent API manufacturing site specializing in ophthalmology”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026